Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Treatment of resistant enterococcal urinary tract infections.

Swaminathan S, Alangaden GJ.

Curr Infect Dis Rep. 2010 Nov;12(6):455-64. doi: 10.1007/s11908-010-0138-8.

PMID:
21308555
2.

Vancomycin-resistant enterococcal urinary tract infections.

Heintz BH, Halilovic J, Christensen CL.

Pharmacotherapy. 2010 Nov;30(11):1136-49. doi: 10.1592/phco.30.11.1136. Review.

PMID:
20973687
3.

Treatment options for vancomycin-resistant enterococcal infections.

Linden PK.

Drugs. 2002;62(3):425-41. Review.

PMID:
11827558
4.

[Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].

Rudy M, Nowakowska M, WiechuĊ‚a B, Zientara M, Radosz-Komoniewska H.

Przegl Lek. 2004;61(5):473-6. Polish.

PMID:
15515808
5.

Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections.

Carson C, Naber KG.

Drugs. 2004;64(12):1359-73. Review.

PMID:
15200349
6.

Successful treatment of vancomycin-resistant Enterococcus faecium pyelonephritis with daptomycin during pregnancy.

Shea K, Hilburger E, Baroco A, Oldfield E.

Ann Pharmacother. 2008 May;42(5):722-5. doi: 10.1345/aph.1K561. Epub 2008 Mar 18.

PMID:
18349306
7.

Treatment of vancomycin-resistant Enterococcus faecium infections.

Lai KK.

Arch Intern Med. 1996 Dec 9-23;156(22):2579-84.

PMID:
8951301
8.

Increasing Antimicrobial Resistance: Therapeutic Implications for Enterococcal Infections.

Levison ME, Mallela S.

Curr Infect Dis Rep. 2000 Oct;2(5):417-423.

PMID:
11095886
9.

Management of complicated urinary tract infections in the era of antimicrobial resistance.

Bader MS, Hawboldt J, Brooks A.

Postgrad Med. 2010 Nov;122(6):7-15. doi: 10.3810/pgm.2010.11.2217. Review.

PMID:
21084776
10.

Emergence and management of drug-resistant enterococcal infections.

Arias CA, Murray BE.

Expert Rev Anti Infect Ther. 2008 Oct;6(5):637-55. doi: 10.1586/14787210.6.5.637. Review.

PMID:
18847403
11.

Epidemiology of bacteriuria caused by vancomycin-resistant enterococci--a retrospective study.

Wong AH, Wenzel RP, Edmond MB.

Am J Infect Control. 2000 Aug;28(4):277-81.

PMID:
10926703
12.

Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections.

Chen YH, Ko WC, Hsueh PR.

Expert Opin Pharmacother. 2013 Apr;14(5):587-96. doi: 10.1517/14656566.2013.778827. Review.

PMID:
23480061
15.

Multidrug-resistant enterococci in animal meat and faeces and co-transfer of resistance from an Enterococcus durans to a human Enterococcus faecium.

Vignaroli C, Zandri G, Aquilanti L, Pasquaroli S, Biavasco F.

Curr Microbiol. 2011 May;62(5):1438-47. doi: 10.1007/s00284-011-9880-x. Epub 2011 Feb 1.

PMID:
21286720
16.

Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).

Zhanel GG, Laing NM, Nichol KA, Palatnick LP, Noreddin A, Hisanaga T, Johnson JL, Hoban DJ; NAVRESS Group.

J Antimicrob Chemother. 2003 Sep;52(3):382-8. Epub 2003 Jul 29.

PMID:
12888592
17.

The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.

Lam S, Singer C, Tucci V, Morthland VH, Pfaller MA, Isenberg HD.

Am J Infect Control. 1995 Jun;23(3):170-80.

PMID:
7677262
18.

Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001.

Critchley IA, Draghi DC, Sahm DF, Thornsberry C, Jones ME, Karlowsky JA.

J Antimicrob Chemother. 2003 Mar;51(3):639-49.

PMID:
12615866
19.

Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.

Gauthier M, Chevalier I, Sterescu A, Bergeron S, Brunet S, Taddeo D.

Pediatrics. 2004 Oct;114(4):e469-76.

PMID:
15466073
20.

The etiology of urinary tract infection: traditional and emerging pathogens.

Ronald A.

Dis Mon. 2003 Feb;49(2):71-82. Review.

PMID:
12601338

Supplemental Content

Support Center